Jublia 10 %

Efinaconazole, the active ingredient in JUBLIA, is an azole antifungal presented as a 10% solution for topical use. It is indicated for the treatment of onychomycosis (toenail fungus) caused by Trichophyton rubrum and Trichophyton mentagrophytes. GNH USA supplies JUBLIA as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

JUBLIA is a prescription medication designed to target and eliminate fungal infections in the toenails. It is applied directly to the affected area and works by disrupting the fungal cell membrane, leading to the death of the fungus.

JUBLIA is an antifungal medication used to treat toenail fungal infections. It is specifically indicated for onychomycosis caused by certain types of fungi.

- Onychomycosis of toenails: Treats fungal infections in the toenails caused by Trichophyton rubrum and Trichophyton mentagrophytes. - Topical application: Applied directly to the affected toenail and surrounding skin to eliminate the fungus. - Long-term treatment: Requires consistent application over several months to ensure the infection is fully cleared.

JUBLIA may cause various side effects, ranging from common to serious.

Common Side Effects: - Ingrown toenail: May occur at the site of application. - Application-site dermatitis: Redness, itching, or swelling around the treated area. - Application-site vesicles: Small blisters or bumps at the application site. - Application-site pain: Discomfort or pain where the medication is applied.

Serious or Rare Side Effects: - Severe allergic reactions: Rash, itching, swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing. - Severe irritation: Intense redness, itching, or swelling that does not subside. - Blisters: Formation of blisters at the application site.

JUBLIA should be used with caution and under the guidance of a healthcare professional.

- Pregnancy: Use only if the potential benefit justifies the potential risk to the fetus. - Breastfeeding: Use with caution, as the safety in nursing women is not established. - Pediatric use: Safety and effectiveness in children under 6 years of age have not been established. - Application site: Avoid contact with eyes, mouth, or vagina. - Flammability: The solution is flammable; avoid heat and flame while applying. - Storage: Store at room temperature: Keep the bottle upright and tightly closed, away from heat or flame, and protect from light and moisture.

JUBLIA may interact with other medications, requiring careful monitoring.

Major Interactions (Avoid): - None identified.

Moderate Interactions (Monitor Closely): - Other topical medications: Avoid using other topical treatments on the same area without consulting a healthcare professional. - Systemic antifungals: Concurrent use with other systemic antifungals should be monitored for potential interactions. - Immunosuppressants: May require careful monitoring when used together.